NeoGenomics Inc (NEO)

NASDAQ
47.89
+0.51(+1.08%)
  • Volume:
    172,839
  • Bid/Ask:
    47.84/47.89
  • Day's Range:
    47.50 - 48.04
  • Type:Equity
  • Market:United States
  • ISIN:US64049M2098
  • CUSIP:00064049M209

NEO Overview

Prev. Close
47.38
Day's Range
47.5-48.04
Revenue
488.69M
Open
47.81
52 wk Range
34.18-61.14
EPS
0.55
Volume
172,839
Market Cap
5.83B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
643,344
P/E Ratio
86.17
Beta
0.67
1-Year Change
33.58%
Shares Outstanding
122,969,995
Next Earnings Date
Nov 02, 2021
What is your sentiment on NeoGenomics Inc?
or
Vote to see community's results!

NeoGenomics Inc News

NeoGenomics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellSellStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Buy

NeoGenomics Inc Company Profile

NeoGenomics Inc Company Profile

Employees
1700

NeoGenomics, Inc. is an operator of a network of cancer-focused testing laboratories. The Company’s customers include Clinical and Pharma. Its Clinical customers include community-based pathology practices, oncology groups, hospitals and academic centers. Its Pharma customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. The Company' Pharma Services segment provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.

Read More
  • I'm still wearing a 20% hit so hoping for a trading to recoup some of the loss if the figures are better than expected. I've been faithful to Boo quite a while but want to release some funds for the SpectrumX pre-ipo. I need an investment without the drama!
    0
    • 10 Bagger!!! 🚀🚀🚀🚀🚀🚀🚀
      0
      • I bought this stock on accident thinking it was NIO does anyone expect growth from this stock or is it just a dud?
        1
        • you might just got really lucky...
          0
      • I bought this stock on accident thinking it was NIO does anyone expect growth from this stock or is it just a dud?
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.